As a means of testing this hypothesis and excluding a possible bias in our experiments, we treated C57BL/6 mice with anti-NK1.1 depleting antibody targeting NKp46+ cells and NKT cells, which have been implicated in tumor immunosurveillance (Figure S1B). This evidence concerns the gene NCR1 and neoplasm.